Literature DB >> 24462445

Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011-2012: Hospital-based Influenza Morbidity & Mortality (HIMM) surveillance.

Kyung-Wook Hong1, Hee Jin Cheong1, Won Suk Choi2, Jacob Lee3, Seong-Heon Wie4, Ji Hyeon Baek5, Hyo Youl Kim6, Hye Won Jeong7, Woo Joo Kim8.   

Abstract

Influenza is an acute respiratory illness, which can be accompanied by complications such as pneumonia. This study was conducted to survey the clinical courses and outcomes of hospitalized adult patients with laboratory-confirmed seasonal influenza. A prospective case-control study was performed in adult influenza patients who were admitted to hospitals participating in the Hospital-based Influenza Morbidity and Mortality (HIMM) surveillance system in Korea from October 2011 to May 2012. Cases with complicated influenza were compared to those without complications. A total of 123 (5.6%) patients among 2184 laboratory-confirmed adult influenza patients were hospitalized during the 2011-2012 influenza epidemic season. Forty (32.5%) experienced 50 complication episodes. Age older than 60 years (P < 0.01), male sex (P = 0.04), diabetes (P < 0.01), chronic cardiovascular disease (P < 0.01) and neuromuscular disease (P = 0.02) were significantly related to development of complications in univariate analysis. Multivariate logistic regression analysis revealed that diabetes (odds ratio [OR] 3.63, 95% confidence interval [CI] 1.15-11.51, P = 0.02) was an independent risk factor for complicated seasonal influenza. C-reactive protein (CRP) was discriminative between complicated and uncomplicated influenza (cutoff value 13 mg/L, sensitivity 70%, specificity 74%). Complicated patients received antibiotics more frequently (P < 0.01) with longer hospital stays (P = 0.01). In conclusion, diabetic patients are at great risk for complicated influenza, and CRP would be useful to predicting complication. Therefore, early interventions such as antiviral therapy should be considered for high risk patients with diabetes, especially those with increased serum CRP level.
Copyright © 2013. Published by Elsevier Ltd.

Entities:  

Keywords:  Complications; Hospitalized; Influenza; Risk factors

Mesh:

Substances:

Year:  2013        PMID: 24462445     DOI: 10.1016/j.jiac.2013.07.001

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  14 in total

1.  Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015).

Authors:  Luzhao Feng; Peng Yang; Tao Zhang; Juan Yang; Chuanxi Fu; Ying Qin; Yi Zhang; Chunna Ma; Zhaoqiu Liu; Quanyi Wang; Genming Zhao; Hongjie Yu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  The antibody response to influenza vaccination is not impaired in type 2 diabetics.

Authors:  Patricia A Sheridan; Heather A Paich; Jean Handy; Erik A Karlsson; Stacey Schultz-Cherry; Michael Hudgens; Sam Weir; Terry Noah; Melinda A Beck
Journal:  Vaccine       Date:  2015-06-01       Impact factor: 3.641

Review 3.  Effects of influenza immunization on pneumonia in the elderly.

Authors:  Jung Yeon Heo; Joon Young Song; Ji Yun Noh; Min Joo Choi; Jin Gu Yoon; Saem Na Lee; Hee Jin Cheong; Woo Joo Kim
Journal:  Hum Vaccin Immunother       Date:  2017-12-19       Impact factor: 3.452

4.  Insights in Public Health: COVID-19 Special Column: The Crisis of Non-Communicable Diseases in the Pacific and the Coronavirus Disease 2019 Pandemic.

Authors:  Si Thu Win Tin; Paula Vivili; Elisiva Na'ati; Solene Bertrand; Ilisapeci Kubuabola
Journal:  Hawaii J Health Soc Welf       Date:  2020-05-01

5.  SARS-CoV-2 infection and diabetes mellitus: A North Eastern Romanian experience.

Authors:  Carmen Manciuc; Dragos Nemescu; Andrei Vata; Georgiana Alexandra Lacatusu
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

6.  Predisposing risk factors for COVID-19 infection: A case-control study.

Authors:  Fatemeh Shahbazi; Manoochehr Solgi; Salman Khazaei
Journal:  Caspian J Intern Med       Date:  2020

Review 7.  Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region.

Authors:  Lance Jennings; Qiu Sue Huang; Ian Barr; Ping-Ing Lee; Woo Joo Kim; Philippe Buchy; Melvin Sanicas; Bruce A Mungall; Jing Chen
Journal:  Influenza Other Respir Viruses       Date:  2018-03-07       Impact factor: 4.380

Review 8.  A comprehensive review on clinical and mechanistic pathophysiological aspects of COVID-19 Malady: How far have we come?

Authors:  Baila Shakaib; Tanzeel Zohra; Aamer Ikram; Muhammad Bin Shakaib; Amna Ali; Adnan Bashir; Muhammad Salman; Mumtaz Ali Khan; Jamil Ansari
Journal:  Virol J       Date:  2021-06-07       Impact factor: 4.099

9.  The Role of Influenza in the Delay between Low Temperature and Ischemic Heart Disease: Evidence from Simulation and Mortality Data from Japan.

Authors:  Chisato Imai; Adrian G Barnett; Masahiro Hashizume; Yasushi Honda
Journal:  Int J Environ Res Public Health       Date:  2016-04-28       Impact factor: 3.390

10.  Incidence and Risk Factors of Pneumonia in Hospitalized Patients with Seasonal Influenza A or B.

Authors:  Seongjun Chu; Sang Joon Park; So My Koo; Yang Ki Kim; Ki Up Kim; Soo Taek Uh; Tae Hyung Kim; Suyeon Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2017-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.